Estrogen signaling impacted immune response in cancer

Estrogen signaling was responsible for immunosuppressive effects in the tumor microenvironment across cancer types, a new study has concluded. These findings pave the way for combining immunotherapeutic treatments with anti-estrogen drugs that may significantly extend survival.